Literature DB >> 21042942

Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases.

Michael D'Angelica1, Peter Kornprat, Mithat Gonen, Ronald P DeMatteo, Yuman Fong, Leslie H Blumgart, William R Jarnagin.   

Abstract

BACKGROUND: Despite improvements in surgery and chemotherapy, most patients develop recurrence after hepatectomy for metastatic colorectal cancer. Data are lacking on the effect of these patterns on outcome.
METHODS: A retrospective review of a prospectively maintained hepatobiliary database was performed. Pattern and timing of recurrence and outcome after recurrence were analyzed. Univariate and multivariate analyses of factors associated with outcome after recurrence were carried out.
RESULTS: From January 1997 through May 2003, a total of 733 patients underwent hepatectomy for colorectal metastases. Of these, 637 patients (87%) were included in the analysis, and in 393 patients (62%), recurrence was documented at the time of last follow-up. Initial recurrence patterns included the following: liver only in 120 patients (31%), lung only in 107 (27%), other single sites in 49 (12%), and multiple sites in 117 (30%). Recurrence occurred within 2 years of hepatectomy in 75% of patients and after 3 years in 11%. Margins at hepatectomy, recurrence pattern, resected recurrence, and disease-free interval from time of colectomy to hepatic metastasis and from time of hepatectomy to recurrence were independently associated with survival as measured from the time of recurrence. Recurrence in the lung, resected recurrence, and time to recurrence after hepatectomy were associated with prolonged survival as measured from the time of hepatectomy and the time of recurrence.
CONCLUSIONS: The timing and pattern of recurrence after hepatic resection for metastatic colorectal cancer are important predictors of long-term survival.

Entities:  

Mesh:

Year:  2010        PMID: 21042942     DOI: 10.1245/s10434-010-1409-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  69 in total

1.  Neo-adjuvant Chemotherapy-Induced Neutropenia Is Associated with Histological Responses and Outcomes after the Resection of Colorectal Liver Metastases.

Authors:  Qichen Chen; Chaorui Wu; Hong Zhao; Jianxiong Wu; Jianjun Zhao; Xinyu Bi; Zhiyu Li; Zhen Huang; Yefan Zhang; Jianguo Zhou; Jianqiang Cai
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

Review 2.  Parenchymal-sparing liver surgery in patients with colorectal carcinoma liver metastases.

Authors:  Fernando A Alvarez; Rodrigo Sanchez Claria; Sebastian Oggero; Eduardo de Santibañes
Journal:  World J Gastrointest Surg       Date:  2016-06-27

Review 3.  Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases.

Authors:  Alexandre Doussot; Nancy E Kemeny; Michael I D'Angelica
Journal:  Hepat Oncol       Date:  2015-07-27

4.  Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.

Authors:  Thomas A Aloia; Giuseppe Zimmitti; Claudius Conrad; Vijaya Gottumukalla; Scott Kopetz; Jean-Nicolas Vauthey
Journal:  J Surg Oncol       Date:  2014-05-21       Impact factor: 3.454

5.  Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.

Authors:  Yoshikuni Kawaguchi; Heather A Lillemoe; Elena Panettieri; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Scott Kopetz; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2019-05-02       Impact factor: 6.113

6.  Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.

Authors:  Amber L Simpson; Alexandre Doussot; John M Creasy; Lauryn B Adams; Peter J Allen; Ronald P DeMatteo; Mithat Gönen; Nancy E Kemeny; T Peter Kingham; Jinru Shia; William R Jarnagin; Richard K G Do; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2017-05-30       Impact factor: 5.344

7.  mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy.

Authors:  E P van der Stok; M Smid; A M Sieuwerts; P B Vermeulen; S Sleijfer; N Ayez; D J Grünhagen; J W M Martens; C Verhoef
Journal:  Mol Oncol       Date:  2016-09-20       Impact factor: 6.603

8.  Good candidates for a third liver resection of colorectal metastasis.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Shunji Okada; Atsuko Iwama; Yutaka Midorikawa; Masamichi Moriguchi; Hisashi Nakayama; Tokio Higaki; Masahiko Sugutani
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

9.  Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer.

Authors:  Andrea Peloso; Eloisa Franchi; Maria C Canepa; Letizia Barbieri; Laura Briani; Jacopo Ferrario; Carolina Bianco; Pietro Quaretti; Silvia Brugnatelli; Paolo Dionigi; Marcello Maestri
Journal:  HPB (Oxford)       Date:  2013-02-20       Impact factor: 3.647

10.  Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference.

Authors:  Mathilde Wagner; Léon Maggiori; Maxime Ronot; Valérie Paradis; Valérie Vilgrain; Yves Panis; Bernard E Van Beers
Journal:  Eur Radiol       Date:  2013-03-02       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.